Novavax and Catalent Announce Closing of Strategic Partnership

NEXT STORY
Apellis Pharmaceuticals Reports Second Quarter 2019 Business Update and Financial Results
PREV STORY
Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

ACR Recommends CMS Make Drug Pricing Demonstration Voluntary; Better Address Financial and Administrative Challenges ...

author_avatar
NASDAQ Market News

CytoDyn Files an IND and a Phase 2 Protocol with the FDA for the Treatment of NASH with Leronlimab

author_avatar
NASDAQ Market News

Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared

author_avatar
NASDAQ Market News